↓ Skip to main content

Dove Medical Press

Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments

Overview of attention for article published in OncoTargets and therapy, June 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#25 of 3,016)
  • High Attention Score compared to outputs of the same age (94th percentile)

Mentioned by

news
3 news outlets

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
48 Mendeley
Title
Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments
Published in
OncoTargets and therapy, June 2011
DOI 10.2147/ott.s14107
Pubmed ID
Authors

Shilpa Gupta, Estrella Carballido, Mayer Fishman

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 19%
Student > Bachelor 7 15%
Researcher 7 15%
Student > Doctoral Student 6 13%
Other 4 8%
Other 9 19%
Unknown 6 13%
Readers by discipline Count As %
Medicine and Dentistry 17 35%
Agricultural and Biological Sciences 11 23%
Nursing and Health Professions 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 5 10%
Unknown 7 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2017.
All research outputs
#1,550,335
of 25,374,917 outputs
Outputs from OncoTargets and therapy
#25
of 3,016 outputs
Outputs of similar age
#6,370
of 122,183 outputs
Outputs of similar age from OncoTargets and therapy
#1
of 3 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,183 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them